FAMILY HYPERURICEMIA WITH RENAL FAILURE – A NEW MUTATION

Slides:



Advertisements
Similar presentations
Chronic Renal Failure(CRF)
Advertisements

Prepared by D. Chaplin Chronic Renal Failure. Prepared by D. Chaplin Chronic Renal Failure Progressive, irreversible damage to the nephrons and glomeruli.
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
Anemia Guidelines and The Use of Erythropoietin in Turkey
DIABETES AND THE KIDNEYS
Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.
Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.
Case report no. 9. Recurrence of amyloid in a kidney allograft Eva Honsová Institute for Clinical and Experimental Medicine Prague, Czech Republic.
Chronic Kidney Disease Ulysses Rosas May 8 th, 2012.
Gout.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Uric Acid Metabolism & Gout
Glomerulopathies –IgA nephropathy IgA nephropathy - Pathogenesis.
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
A Red Scaly Rash Small Group Teaching Problem Based Learning Dermatology Department College of Medicine King Saud University.
Patient developed acute and chronic renal failure in 1999 associated with a renal stone. History, and a diagnosis of chronic pyelonephritis. She was started.
National University of Singapore Department of Surgery OSCE 24 January 2005 Warning! Begin only when told to do so Begin.
25th European Congress Pathology August-September 2013 Lisbon Slide Seminar Electron Microscopy/Nephropathology Electron microscopy in focus: native and.
Kidney Function Tests. Kidney Function Tests Contents: Kidney functions Functional units Renal diseases Routine kidney function tests Serum creatinine.
Chronic Kidney Disease (CKD) Epidemiology A NEW EPIDEMIC: CHRONIC KIDNEY DISEASE IN GENERAL POPULATION REAL PREVALENCE AND RELATED FACTORS Josep M. Galceran,
January 27, Epidemiology 1/685 pediatric admissions Lower incidence than adults Higher crystal formation inhibitors in urine M>F Most common stones.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
History A 50 y/o was referred for evaluation of azotemia. 10 yrs ago, he experienced sudden onset of pain on his right big toe. His serum uric acid was.
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
Chronic renal failure and common accompanying diseases Hradec Králové, November 2007 © by Adrian Franke.
Kidney Disorders By Amir Ashkan Ashrafian M.D.  A spectrum of different pathophysiologic processes associated with abnormal kidney function and a progressive.
Renal Pathophysiology III : Diseases that affect the kidney and urinary tract Acute and chronic renal failure.
Clinical Decision on A Diagnostic Test. Clinical Question In a middle aged man with primary gout and azotemia, can a urine uric acid to creatinine ratio.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
Chapter 37 Chronic Kidney Disease: The New Epidemic
TRIGGER  Ali is a 50-year-old engineer who presented to Dr. Khalid with itching all over his body for the last few weeks. Recently he has noticed that.
به نام دوست. C ASE PRESENTATION Dr.Pardis Nematollahi By : Amir vard.
Sickle Cell Nephropathy Sickle cell disease (SCD) is an autosomal recessive hemoglobinopathy caused by a point mutation in the β-globin chain of haemoglobin,
Revision for Clinical Biochemistry Lab
CARLY LAURAINE KEENE STATE DIETETIC INTERN SAMARITAN MEDICAL CENTER Final Case Study Presentation.
Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%
Mansoura International Hospital Mansoura International Hospital
What Causes Wilson Disease? Wilson disease is caused by mutations in the ATP7B gene. This gene makes an enzyme that is involved in copper transport.
Kidney Stones Renal Block 1 Lecture.
Gout.
Effects of Uric acid- lowering therapy on renal outcomes: a systematic review and meta-analysis Nephrol Dial Transplant (2014) 29: Vaughan Washco.
Uric Acid Presented By Assist.Lecturer Aseel Ghassan Daoud
Case Report: Cutaneous Mastocytosis in Infant
Adult polycystic kidney disease
U # /121 Cad Tx 14/05/2004 Creatinine early December US normal.
Revision for Clinical Biochemistry Lab
History Salient Features Physical Exam
Characterization of VHL promoter variants in patients suspected of Von Hippel Lindau Saleh Albanyan, Rachel Giles, Raymond H Kim, MD/PhD Division of.
CELL DIVISION GOING WRONG: Cancer
Kidney Function Tests.
KIDNEY STONES By: Reem M Sallam, MD, MSc, PhD
A CASE OF NEUROFIBROMATOSIS
Asmaa Hmaid Esraa Shbair
A Red Scaly Rash ..
  URIC ACID Muthana A. Al-Shemeri.
Introduction and Abstract Investigations and Images
Acute and Chronic Renal Failure
Diuretics, Kidney Diseases Urine R&M
A young patient with multiple myeloma
IgA Nephropathy Southwest Nephrology Symposium February 24th 2018.
Hypertension evaluation
Volume 66, Issue 1, Pages (July 2004)
1.4 – Changes in Cell Division
The risk of siblings being affected depends on the mode of inheritance and the gender of the affected parent (in X-linked disease). The risk of siblings.
Volume 67, Issue 4, Pages (April 2005)
Clinical Background. A clinically applicable approach to continuous prediction of future acute kidney injury.
Presentation transcript:

FAMILY HYPERURICEMIA WITH RENAL FAILURE – A NEW MUTATION Ilze Andersone a Vladimirs Strazdins a Karl Lhotta b Florian Kronenberg c a Nephrology Department, University Hospital for Children, Riga, Latvia b Clinical Division of Nephrology, Innsbruck Medical University, Austria c Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Austria

Prepublicized presentation, Riga & Innsbruck Introduction We present the family case characterized by: Hyperuricemia Renal failure Caused by new (previously unknown) UMOD gene mutation February 8, 2007 Prepublicized presentation, Riga & Innsbruck

Prepublicized presentation, Riga & Innsbruck The Father The historically first patient in the family was father (KS). Diagnosed with terminal renal failure and started on HD in 1998, renal biopsy not performed. Supposed ESRD cause recorded as chronic glomerulonephritis. Tx in 2000, failed in 3 years. HD restarted in 2004. Hyperuricemia was never diagnosed. February 8, 2007 Prepublicized presentation, Riga & Innsbruck

Prepublicized presentation, Riga & Innsbruck The Daughter Part 1 Elder daughter (age 22, lives in Austria) from the KS’s first wife. Presented in 1999 at age 15 with episodic macrohematuria. Primary investigations showed renal failure (GFR 39,68 ml/min/1,73 m2) and anemia (Hb 9,3 g/dl). Subcutaneous Erythropoietin alpha, oral iron and ACEI for renoprotection were started. Renal biopsy performed in early 2000 showed only tubulo-interstitial lesion with intact glomeruli. February 8, 2007 Prepublicized presentation, Riga & Innsbruck

Prepublicized presentation, Riga & Innsbruck The Daughter Part 2 July 2002: surgery due to pain and swelling of the left big toe (described by surgeons as "lymphoma"). X-ray December 2002: multiple cystic lesion at the same location. Surgery February 2003: the biopsy of the removed cystic tissues showed multiple uric acid crystal deposits. Blood chemistry: hyperuricemia 679,6 mcmol/l. Diagnosed as familial juvenile goat nephropathy, Allopurinol added. February 8, 2007 Prepublicized presentation, Riga & Innsbruck

Prepublicized presentation, Riga & Innsbruck The Elder Son Elder son (age 12) from the KS’s second wife (AS) presented in May 2003 at age 9 with serum urea 10,2 mmol/l, creatinine 85 mcmol/l, GFR 62,14 ml/min/1,73 m2, uric acid 521,4 mcmol/l. Allopurinol and Captopril started. Additional anamnesis discovered microhematuria episodes from the early childhood. No further investigation done at the time. February 8, 2007 Prepublicized presentation, Riga & Innsbruck

Prepublicized presentation, Riga & Innsbruck The Younger Son Younger son (current age 4) from the KS’s second wife (DS) was first investigated in October 2006. Serum urea, creatinine and uric acid were within the normal range. 24-hour urine showed more than two-fold uric acid excretion. Allopurinol started. February 8, 2007 Prepublicized presentation, Riga & Innsbruck

Prepublicized presentation, Riga & Innsbruck Genetic Check Performed in Innsbruck to all family members: Unknown UMOD mutation found. The mutation is present in the father and all three children. It is a G/T-SNP and leads to substitution of ASP to TYR on position 196. It is a “hot spot” where other mutations have been described. February 8, 2007 Prepublicized presentation, Riga & Innsbruck

Prepublicized presentation, Riga & Innsbruck Discussion The case is somewhat anecdotal, since Uricopathy was first diagnosed in the daughter accidentally while evaluating the bone biopsy after the orthopedic surgery, though renal failure was already present. The father was diagnosed only retrospectively when the daughter's diagnosis was confirmed. Suggestion. The routine uric acid testing in all CKD cases is advocated. February 8, 2007 Prepublicized presentation, Riga & Innsbruck

Prepublicized presentation, Riga & Innsbruck Comments The father’s Tx failure might also be caused by untreated hiperuricemia. Colleagues were warned on Allopurinol and UA check necessity. The mutation seems to be autosomal dominant. There seem to be a high risk of family recurrence also in further generations. February 8, 2007 Prepublicized presentation, Riga & Innsbruck